P15-05. Evaluation and recommendations on good clinical laboratory practice (GCLP) guidelines for phase I-III HIV vaccine clinical trials

Podobne zapisy

• P15-05. Evaluation and recommendations on good clinical laboratory practice (GCLP) guidelines for phase I-III HIV vaccine clinical trials
  od: Stevens G, i wsp.
  Wydane: (2009-10-01)
• Evaluation and Recommendations on Good Clinical Laboratory Practice Guidelines for Phase I–III Clinical Trials
  od: Sarzotti-Kelsoe, Marcella, i wsp.
  Wydane: (2009)
• Implementation of Good Clinical Laboratory Practice (GCLP) guidelines within the External Quality Assurance Program Oversight Laboratory (EQAPOL)
  od: Todd, Christopher A., i wsp.
  Wydane: (2013)
• International Technology Transfer of a GCLP-Compliant HIV-1 Neutralizing Antibody Assay for Human Clinical Trials
  od: Ozaki, Daniel A., i wsp.
  Wydane: (2012)
• P06-07. A GCLP accredited Clinical Trial Laboratory Network in Africa and India: a collaborative effort between IAVI and in country research organizations
  od: Stevens, G, i wsp.
  Wydane: (2009)